Literature DB >> 22995683

Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.

Hideki Houzen1, Masaaki Niino, Makoto Hirotani, Toshiyuki Fukazawa, Seiji Kikuchi, Keiko Tanaka, Hidenao Sasaki.   

Abstract

OBJECTIVE: To carry out the third epidemiologic surveillance of multiple sclerosis (MS) in Tokachi province, on the northernmost island of Japan, and to compare the results of the present survey on the prevalence, incidence, and characteristics of MS and neuromyelitis optica (NMO) with those of previous surveys performed in 2001 and 2006.
METHODS: A data processing sheet was sent to all MS-related institutions in Tokachi province, and all sheets were collected in March 2011. The criteria of Poser were used for diagnosing MS and the criteria proposed by Wingerchuk for diagnosing NMO. We then compared the results of the present survey with those of previous surveys performed in 2001 and 2006 in the same community.
RESULTS: Fifty-seven patients diagnosed with MS according to the criteria of Poser were identified. The prevalence was 16.2/100,000 in 2011, which was higher than in the previous studies. The female/male ratio of MS was 2.63, 2.75, and 3.38 in 2001, 2006, and 2011, respectively. Three patients fulfilled the criteria for diagnosis of NMO in 2011; the prevalence of NMO was 0.9/100,000.
CONCLUSIONS: The results of this study suggest that the prevalence and the female predominance of MS have been increasing, due to an increase in the incidence after 1990, and that the prevalence of NMO is relatively low in northern Japan.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22995683     DOI: 10.1016/j.jns.2012.08.032

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

1.  Latitude has more significant impact on prevalence of multiple sclerosis than ultraviolet level or sunshine duration in Japanese population.

Authors:  Masako Kinoshita; Kaoru Obata; Masami Tanaka
Journal:  Neurol Sci       Date:  2015-03-10       Impact factor: 3.307

2.  Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta.

Authors:  Sara Salama; Hazem Marouf; M Ihab Reda; Amal R Mansour; Osama ELKholy; Michael Levy
Journal:  J Neuroimmunol       Date:  2018-08-29       Impact factor: 3.478

Review 3.  Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics.

Authors:  DeRen Huang
Journal:  Neurosci Bull       Date:  2015-12       Impact factor: 5.203

Review 4.  The hygiene hypothesis in autoimmunity: the role of pathogens and commensals.

Authors:  Jean-François Bach
Journal:  Nat Rev Immunol       Date:  2017-10-16       Impact factor: 53.106

5.  Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Authors:  Eoin P Flanagan; Philippe Cabre; Brian G Weinshenker; Jennifer St Sauver; Debra J Jacobson; Masoud Majed; Vanda A Lennon; Claudia F Lucchinetti; Andrew McKeon; Marcelo Matiello; Nilifur Kale; Dean M Wingerchuk; Jay Mandrekar; Jessica A Sagen; James P Fryer; Angala Borders Robinson; Sean J Pittock
Journal:  Ann Neurol       Date:  2016-04-04       Impact factor: 10.422

6.  Multiple sclerosis in Japan appears to be a milder disease compared to the UK.

Authors:  L Piccolo; G Kumar; I Nakashima; T Misu; Y Kong; B Wakerley; S Ryan; A Cavey; K Fujihara; Jacqueline Palace
Journal:  J Neurol       Date:  2015-01-22       Impact factor: 4.849

Review 7.  Demographic and clinical features of neuromyelitis optica: A review.

Authors:  L Pandit; N Asgari; M Apiwattanakul; J Palace; F Paul; M I Leite; I Kleiter; T Chitnis
Journal:  Mult Scler       Date:  2015-04-28       Impact factor: 6.312

Review 8.  Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis.

Authors:  Masoud Etemadifar; Zahra Nasr; Behrang Khalili; Maryam Taherioun; Reza Vosoughi
Journal:  Mult Scler Int       Date:  2015-04-20

9.  Hospitalization rates and discharge status in multiple sclerosis.

Authors:  Sanober Nusrat; David Levinthal; Klaus Bielefeldt
Journal:  Mult Scler Int       Date:  2013-05-13

10.  Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.

Authors:  Sachiko Miyake; Sangwan Kim; Wataru Suda; Kenshiro Oshima; Masakazu Nakamura; Takako Matsuoka; Norio Chihara; Atsuko Tomita; Wakiro Sato; Seok-Won Kim; Hidetoshi Morita; Masahira Hattori; Takashi Yamamura
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.